Suma Krishnan, President, R&D at Krystal Biotech, Inc. (KRYS), sold 100,000 shares at $82.20 ($8.1M) on 2022-08-05, disclosed to the SEC on 2022-08-09.
Open-market sale of $8.1M KRYS by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.22 | 8,992 | $721K | 8.9% |
| 2 | $80.22 | 8,992 | $721K | 8.9% |
| 3 | $80.24 | 9,088 | $729K | 9.0% |
| 4 | $80.24 | 9,088 | $729K | 9.0% |
| 5 | $81.61 | 13,058 | $1.1M | 13.1% |
| 6 | $81.61 | 13,058 |
| $1.1M |
| 13.1% |
| 7 | $81.62 | 13,432 | $1.1M | 13.5% |
| 8 | $81.62 | 13,432 | $1.1M | 13.5% |
| 9 | $82.19 | 2,854 | $235K | 2.9% |
| 10 | $82.19 | 2,854 | $235K | 2.9% |
| 11 | $82.20 | 2,576 | $212K | 2.6% |
| 12 | $82.20 | 2,576 | $212K | 2.6% |
| Total | $81.18 avg | 100,000 | $8.1M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |